Sign in to view content

First Results From a Phase 1B Multiple-Dose Study of KSI-301: A Novel Anti-VEGF Antibody Biopolymer Conjugate (ABC) With Extended Durability

Pravin U. Dugel, MD

Video
Published 2019

Pravin U. Dugel, MD

AMD Neovascular Part II Symposium

Related

The Functional Impact of Fluctuating Retinal Thickness in the IVAN and CATT Trials: A Meta-Analysis
Usha Chakravarthy
Updates from the Field
2019
Episode 11: Endophthalmitis after Intravitreal Anti-VEGF Injections with Dr. David Almeida
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients Treated With Intravitreal Aflibercept or Ranibizumab in the VIEW studies
Robert L. Avery, MD
On Demand Cases, Courses, and Papers
2017

Category: AMD-Neovascular

See more